Double-Blind, Randomized Trial Comparing Efficacy and Safety of Continuing Olanzapine Versus Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia or Schizoaffective Disorder

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s3153
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Long-Term Safety and Efficacy of Olanzapine Long-Acting Injection in Patients With Schizophrenia or Schizoaffective Disorder

International Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2014English

Randomized, Double-Blind Trial of Olanzapine Versus Placebo in Patients Prodromally Symptomatic for Psychosis

American Journal of Psychiatry
PsychiatryMental Health
2006English

Aripiprazole Added to Overweight and Obese Olanzapine-Treated Schizophrenia Patients

Journal of Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2009English

Effects of Olanzapine, Risperidone and Haloperidol on Prepulse Inhibition in Schizophrenia Patients: A Double-Blind, Randomized Controlled Trial

Schizophrenia Research
PsychiatryMental HealthBiological Psychiatry
2007English

Quetiapine Versus Haloperidol in the Treatment of Delirium: A Double-Blind, Randomized, Controlled Trial

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2013English

Aripiprazole Versus Quetiapine in Treatment-Resistant Obsessive–compulsive Disorder: A Double-Blind Clinical Trial

Therapeutic Advances in Psychopharmacology
2014English

Vitamin D Supplementation Improves SIRT1, Irisin, and Glucose Indices in Overweight or Obese Type 2 Diabetic Patients: A Double-Blind Randomized Placebo-Controlled Clinical Trial

BMC Family Practice
Family Practice
2020English

Use of Natural Language Processing to Identify Obsessive Compulsive Symptoms in Patients With Schizophrenia, Schizoaffective Disorder or Bipolar Disorder

Scientific Reports
Multidisciplinary
2019English

Risperidone vs Olanzapine in Treatment of Schizophrenia: A Double Blind Clinical Trial

MOJ Addiction Medicine & Therapy
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy